Medicinal Genomics
Nicholas Lawson is an experienced Field Application Scientist at Medicinal Genomics since October 2019. Previously, Nicholas served as a Scientist at Phytelligence Inc., where responsibilities included leading the genetic analysis lab and developing KASP assays for varietal verification and plant disease testing. Prior roles include Junior Associate at OGZ Holdings LLC and Lab Manager at Landrace Labs. Nicholas also gained research experience as a Graduate Research Assistant at the University of Arkansas, focusing on molecular plant biology, data analysis, and various laboratory techniques. Educational credentials include a Master’s Degree in Cell/Cellular and Molecular Biology from the University of Arkansas and a Bachelor’s in Biology and Philosophy from Missouri Southern State University.
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.